Flu exams from R-Biopharm additionally detect new virus variants

Darmstadt, November 25, 2022 – The flu season has begun and completely different virus variants are additionally circulating in Germany. With the flu exams from biotechnology firm R-Biopharm, sufferers rapidly have certainty: Its RIDA®GENE Flu assays additionally reliably detect the 2 novel variants. The corporate made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the UK, and the H3N2 subtype, which was rampant in Denmark within the spring and is at present dominating influenza exercise in Germany.

“Mutations within the goal gene (MP gene) can have an effect on the diagnostic efficiency of influenza screening assays, producing false-negative take a look at outcomes,” explains Dr. Andreas Simons, Head of Product Administration at R-Biopharm. “Alignments of the detection techniques we used with the described sequences of the 2 novel virus variants confirmed no mismatches. Their dependable detection just isn’t affected by the described mutations.”

This implies laboratories can proceed to reliably verify or rule out influenza infections utilizing R-Biopharm’s RIDA®GENE (PG0505, PG0545, PG6825) assays. The exams are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.

About R-Biopharm
R-Biopharm AG, situated in Darmstadt, is certainly one of Germany’s main biotechnology corporations. Based in 1988, the corporate is family-run within the second era and considers itself as a pioneer for well being and high quality of life. Its aspiration: to supply the best potential precision, security, readability and certainty in prevention, remedy and therapeutic. To this finish, R-Biopharm develops applied sciences, merchandise and options for Medical Diagnostics, Vitamin Care and Meals and Feed Analytics – and does so in internationally acknowledged high quality. R-Biopharm is the world market chief for take a look at techniques within the discipline of allergen evaluation.

R-Biopharm unites analysis, growth and gross sales underneath one roof in an effort to reply to ever new challenges with agile processes and to accompany the steadily rising world inhabitants into a brand new well being period. The corporate is represented in additional than 120 international locations – by way of 29 subsidiaries and 120 distributors. It employs round 1,400 individuals worldwide (690 at its headquarters in Darmstadt) and was repeatedly acknowledged with the “Sustainability Award” for sustainable and worthwhile development.

Press contact:
Simone Feiler
Head of Company Model Communication


R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt
Telephone: 0 61 51 – 81 02-538
Cell: 0 160 – 55 273 60
Fax: 0 61 51 – 81 02-40
E mail: [email protected]

Supply hyperlink

Leave a Reply

Your email address will not be published.